Fariba Ahmadizar

Fariba Ahmadizar, PharmD, MSc and PhD in Epidemiology, is a senior Assistant Professor at the Data Science and Biostatistics Department. 

Research and Academic Contributions: Fariba interest is in biomarker discovery in cardiometabolic disorders, focusing on the intersection of omics (e.g., genetics and metabolomics), risk factors, drug response, and public health. 
Fariba is a Principal Investigator leading various initiatives and consortia, demonstrating her commitment to advancing research and education. She is currently the Principal Investigator of the observational Post-Authorization Safety Study for the Janssen COVID-19 vaccine. Her significant contributions extend to numerous fellowships, grants, and supervision of postdocs, Ph.D., and MSc students.
Fariba is also a Visiting Professor of Pharmacoepidemiology at Shiraz University of Medical Sciences, Iran. 
Farib actively contributes to the scientific community by organizing and coordinating pre-conference courses, serving as an international scientific coordinator, and holding editorial roles in reputable journals. Her extensive reviewing activities for renowned journals reflect her dedication to maintaining high research standards.
Contact me via e-mail if you would like to reach out:
f.ahmadizar@umcutrecht.nl